case_images: PMC8493867_01
case_images: PMC8493867_02
case_images: Social Responsiveness Scale-2 (SRS) sub-scores prior to the initiation of omalizumab (blue) and after the 6 month treatment period (red).
case_images: fped-09-714111-g0002.jpg
case_images: PMC8493867_02_fped-09-714111-g0002.jpg
case_images: F2
case_images: These results are shown in Figure 2 (SRS-2), Figure 3 (RBS-R), Figure 4 (ABC), Figure 5 (PSQI), and Figure 6 (ESS, GAD7, RCAT, and CGI).
case_images: Aberrant Behavior Checklist (ABC) sub-scores prior to the initiation of omalizumab (blue) and after the 6 month treatment period (red).
case_images: fped-09-714111-g0003.jpg
case_images: PMC8493867_02_fped-09-714111-g0003.jpg
case_images: F3
case_images: These results are shown in Figure 2 (SRS-2), Figure 3 (RBS-R), Figure 4 (ABC), Figure 5 (PSQI), and Figure 6 (ESS, GAD7, RCAT, and CGI).
case_images: Repetitive Behavior Scale-Revised (RBS-R) sub-scores prior to the initiation of omalizumab (blue) and after the 6 month treatment period (red).
case_images: fped-09-714111-g0004.jpg
case_images: PMC8493867_02_fped-09-714111-g0004.jpg
case_images: F4
case_images: These results are shown in Figure 2 (SRS-2), Figure 3 (RBS-R), Figure 4 (ABC), Figure 5 (PSQI), and Figure 6 (ESS, GAD7, RCAT, and CGI).
case_images: Pittsburgh Sleep Quality Index (PSQI) sub-scores prior to the initiation of omalizumab (blue) and after the 6 month treatment period (red).
case_images: fped-09-714111-g0005.jpg
case_images: PMC8493867_02_fped-09-714111-g0005.jpg
case_images: F5
case_images: These results are shown in Figure 2 (SRS-2), Figure 3 (RBS-R), Figure 4 (ABC), Figure 5 (PSQI), and Figure 6 (ESS, GAD7, RCAT, and CGI).
case_images: Total scores before initiation of omalizumab (blue) and after the treatment period (red) for the Epworth Sleepiness Scale (ESS), General Anxiety Disorder 7-item (GAD-7) scale, Clinical Global Impressions - Severity (CGI-S) scale, and the Rhinitis Control Assessment Test (RCAT). In contrast to other parameters, RCAT scores indicate better improvement with higher scores, while the rest of the tests indicate better improvement with lower scores. The Clinical Global Impressions - Improvement (CGI-I) was rated a 2 at the conclusion of the treatment period, indicating "much improved" symptoms.
case_images: fped-09-714111-g0006.jpg
case_images: PMC8493867_02_fped-09-714111-g0006.jpg
case_images: F6
case_images: These results are shown in Figure 2 (SRS-2), Figure 3 (RBS-R), Figure 4 (ABC), Figure 5 (PSQI), and Figure 6 (ESS, GAD7, RCAT, and CGI).